Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Endocrine-Related Cancer|August 12, 2010
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesisJennifer F Barger, David R PlasProceedings of the National Academy of Sciences of the United States of America|January 26, 2011
Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiencyPreeti Tandon, Catherine A Gallo, Shikha Khatri, et al.Cancer Biology & Therapy|October 12, 2010
Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycinJennifer F Barger, Catherine A Gallo, Kyle A Torni, et al.Respiratory Medicine|April 26, 2015
MicroRNA as tools and therapeutics in lung cancerJennifer F Barger, S Patrick Nana-SinkamCurrent Opinion in Cell Biology|February 25, 2009
Tubers and tumors: rapamycin therapy for benign and malignant tumorsDavid R Plas, George ThomasTrends in Endocrinology and Metabolism: TEM|February 21, 2002
Cell metabolism in the regulation of programmed cell deathDavid R Plas, Craig B ThompsonThe Journal of Biological Chemistry|January 9, 2003
Akt activation promotes degradation of tuberin and FOXO3a via the proteasomeDavid R Plas, Craig B ThompsonOncogene|November 17, 2005
Akt-dependent transformation: there is more to growth than just survivingDavid R Plas, Craig B ThompsonNature Immunology|May 29, 2002
Homeostatic control of lymphocyte survival: potential origins and implicationsDavid R Plas, Jeffrey C Rathmell, Craig B ThompsonPageof 7